History & Overview Annual Report President's Pages Center News Community Affairs
Make a Gift Yankees Universe Fund Fred's Team Donating Blood & Platelets Volunteering Thrift Shop Park Avenue Potluck Cookbook
Press Releases Information for Journalists News@MSKCC
Manhattan New Jersey Long Island Westchester
Working at Memorial Sloan-Kettering Work Sites College Recruitment About Nursing Job Fairs & Career Days Job Search & Apply Online
Making an Appointment
Caroline's Story
Caroline's courageous battle

Acute myelogenous leukemia (AML) is responsible for nearly 15 percent of all childhood leukemias. In this form of leukemia, a change, or mutation, in the DNA of an immature white blood cell, called a myeloid cell, causes the cell to grow and multiply in an uncontrolled way. (Immature myeloid cells originate in the bone marrow.) These uncontrolled cells infiltrate the body's organs and interfere with their function. The cells also interfere with the body's ability to produce other types of cells normally. There are about 300 new cases of AML diagnosed in children in the United States every year. No one is sure exactly what causes leukemia.

  • Symptoms
    The symptoms of AML include fatigue and a feeling of not being well. Many patients also have bone pain.
  • Diagnosis
    To diagnose AML, doctors will do a physical exam and draw a sample of blood to do a complete blood count, or CBC.
  • Staging
    There are many factors that physicians consider when developing a treatment strategy.
  • Treatment
    AML is usually treated with chemotherapy drugs -- drugs that are toxic to the leukemia cells and stop them from growing.

Last Updated: Mar. 9, 2006
PrintEmail This Page